Explanatory note on new interim order to advance COVID-19 clinical trials
IO No. 2 supports Canada’s continued focus on dealing with the significant risk that COVID-19 continues to pose to the health and safety of Canadians.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-05-28
Data overview
- Formats
- HTML
- File languages
- English, French